Seth D Walker MD

Asthma & COPD, Critical Care Medicine, Cystic Fibrosis, Infectious Disease

Staff physician, Piedmont Pulmonary and Critical Care Medicine

Summary

Dr. Seth Walker is a pulmonologist based in Atlanta, GA, specializing in asthma, COPD, critical care medicine, cystic fibrosis, and infectious disease. He completed his residency in internal medicine/pediatrics at Virginia Commonwealth University Health System and a fellowship in pulmonary disease and critical care medicine at the University of Rochester. Dr. Walker has held notable positions including Director of the Adult Cystic Fibrosis Program at University Hospitals Cleveland Medical Center and Emory University Hospital. As an associate professor at Case Western Reserve University, he contributed significantly to research in cystic fibrosis, with multiple publications in prestigious journals like The Lancet and The New England Journal of Medicine. His areas of expertise include bronchiectasis, common variable immunodeficiency, and critical care medicine.

University of Rochester Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
Virginia Commonwealth University Health SystemResidency, Internal Medicine/Pediatrics, 2001 - 2005
West Virginia University School of MedicineClass of 2001

PubMed

41 citations
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis.
Seth Walker, Patrick A. Flume, John McNamara, Melinda Solomon, Mark A. Chilvers
Journal of Cystic Fibrosis. 2019-09-01
19 citations
Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial
Vin Tangpricha, Joshua Lukemire, Yuqing Chen, Jose N. Binongo, Suzanne E. Judd
The American Journal of Clinical Nutrition. 2019-03-01
179 citations
Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study
Margaret Rosenfeld, Claire E. Wainwright, Mark Higgins, Linda T Wang, Charlotte M. McKee
The Lancet. Respiratory Medicine. 2018-07-01

Journal Articles

Tidal breathing responses to albuterol and normal saline in infants with viral bronchiolitis
(1) Scarlett EE, Walker S, Rovitelli A, and Ren CL, Pediatric Allergy, Immunology, and Pulmonology, 12/1/2012
Refusal of Venous Thromboembolism Prophylaxis and Incidence of Thrombosis in Patients with Cystic Fibrosis
Taryn S. Murray, PharmD, BCPS; Nicole L. Metzger, PharmD, BCPS; Melissa M. Chesson, PharmD, BCPS; Seth D. Walker, MD, PULMONARY RESEARCH AND RESPIRATORY MEDICINE – OPEN JOURNAL, 12/28/2017
When will the Tobacco Control Act be considered a failure?
Walker SD, Austin J Pulm Respir Med, 2014

An Open-Label Extension Study of Ivacaftor in Children with CF and a CFTR Gating Mutation Initiating Treatment at Age 2-5 Years (KLIMB)November 1st, 2019
FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR MutationsJune 25th, 2019
Symdeko Approved to Treat Younger Cystic Fibrosis PatientsJune 24th, 2019
Join now to see all